Nuo Therapeutics Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Financials (USD)
Sales 2022 | 112K | Sales 2023 | 609K | Capitalization | 24.33M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | 543 x |
Net cash position 2022 | 1.72M | Net cash position 2023 | 673K | EV / Sales 2023 | 38.9 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-7.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.31% |
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Peter Clausen
COO | Chief Operating Officer | 58 | 08-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Eric Winzer
BRD | Director/Board Member | 67 | 09-01-29 |
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Paul D. Mintz
BRD | Director/Board Member | 75 | 17-04-06 |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.05% | 22.25B | |
-14.77% | 21.68B | |
-8.86% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |